Avapritinib bulk supplier for pharma manufacturers

Avapritinib 25 mg, 100 mg, 200 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 25 mg, 100 mg, 200 mg

Reference Brands: Ayvakyt (USA/EU)

Avapritinib is a targeted oncology therapy used to treat gastrointestinal stromal tumors (GIST) with PDGFRA exon 18 mutations. It works by inhibiting mutant tyrosine kinases, slowing tumor growth and controlling disease progression. Available as oral capsules in strengths of 25 mg, 100 mg, and 200 mg, Avapritinib is typically administered once daily under specialist supervision.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Avapritinib — third party manufacturing & bulk supply

Avapritinib 25 mg, 100 mg, 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Avapritinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Avapritinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Avapritinib →

Back to Listing

Frequently Asked Questions

Avapritinib is listed as Capsules in 25 mg, 100 mg, 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Avapritinib is referenced against Ayvakyt (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.